SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Director/PDMR Shareholding

30 Apr 2026 13:05

RNS Number : 6388C
CLS Holdings PLC
30 April 2026
 

CLS Holdings plc

 

(the "Company", the "Group")

 

Notification of Transaction of Persons Discharging Managerial Responsibilities ("PDMR")

 

CLS Holdings plc Long Term Incentive Plan ("LTIP")

 

 

CLS Holdings plc announces that Fredrik Widlund, Chief Executive Officer and Director of the Company, and Harry Stokes, Chief Financial Officer and Director of the Company, have been awarded nil cost options over a number of ordinary shares of 2.5 pence each in the Company ("Ordinary Shares") as set out below (the "Awards") on 29 April 2026.

 

PDMR Plan Participant

Award Plan

No of Ordinary Shares granted pursuant to Awards

Award Type

Fredrik Widlund

 

LTIP

 

950,407

Performance Share Award

475,203

Restricted Share Award

Harry Stokes

LTIP

443,877

Performance Share Award

221,938

Restricted Share Award

 

The terms of the Awards align to the new hybrid award policy envisaged under the new Directors' Remuneration Policy approved at the 2026 Annual General Meeting and as set out in the Annual Report and Accounts 2025.

 

Subject to the LTIP rules, the Awards will vest on the third anniversary of the date of grant, subject to continued service and the achievement of performance targets or underpin conditions (as relevant). Details of performance targets and underpin conditions can be found in the Directors' Remuneration Report within the Company's Annual Report and Accounts 2025.

 

Vested Awards will be subject to an additional two-year holding period (net of sales for tax).

 

The notification is made in accordance with the UK Market Abuse Regulation.

 

Enquiries:

David Fuller

Company Secretary

CLS Holdings plc

Tel: +44 (0) 20 7582 7766

 

Notification of Dealing Form

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name(s)

Fredrik Widlund

2

 

Reason for the notification

a)

Position/status

 

Chief Executive Officer

 

b)

Initial notification/amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

CLS Holdings plc

b)

LEI

 

213800A357TKB2TD9U78

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

Ordinary Shares of 2.5p

 

Identification code: GB00BF044593

 

b)

Nature of the transaction

Award of nil cost options under the CLS Holdings plc Long Term Incentive Plan

c)

Price(s) and volume(s)

 Price

 

Volume

 

1. Nil

2. Nil

1. 950,407 (PSA)

2. 475,203 (RSA)

d)

- Aggregated information

- Price

 

N/A single transactions

Nil

e)

Date of the transaction

 

29 April 2026

f)

Place of the transaction

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name(s)

Harry Stokes

2

 

Reason for the notification

a)

Position/status

 

Chief Financial Officer

 

b)

Initial notification/amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

CLS Holdings plc

b)

LEI

 

213800A357TKB2TD9U78

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument

Ordinary Shares of 2.5p

 

Identification code: GB00BF044593

 

b)

Nature of the transaction

Award of nil cost options under the CLS Holdings plc Long Term Incentive Plan

c)

Price(s) and volume(s)

 Price

 

Volume

 

1. Nil

2. Nil

1. 443,877 (PSA)

2. 221,938 (RSA)

d)

- Aggregated information

- Price

 

N/A single transactions

Nil

e)

Date of the transaction

 

29 April 2026

 

f)

Place of the transaction

Outside a trading venue

 

 

- end -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKKBKBBKDNQN
Date   Source Headline
5th Oct 20225:13 pmRNSDirector/PDMR Shareholding
4th Oct 20221:12 pmRNSDirector/PDMR Shareholding
29th Sep 202211:26 amRNSDirector/PDMR Shareholding
23rd Sep 20223:06 pmRNSDirector/PDMR Shareholding
22nd Sep 20223:41 pmRNSDirector/PDMR Shareholding
16th Sep 20224:56 pmRNSCompletion of Tender Offer and Total Voting Rights
15th Sep 20223:57 pmRNSDirector/PDMR Shareholding
12th Sep 20224:14 pmRNSResult of Tender Offer
9th Sep 202212:23 pmRNSResult of AGM
15th Aug 20224:27 pmRNSTender Offer
10th Aug 20224:19 pmRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSHalf-year Results
3rd Aug 20227:00 amRNSCLS announces the sale of three properties
2nd Aug 20225:38 pmRNSNotice of Results
14th Jul 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 202210:31 amRNSCLS reclassified as REIT on EPRA index
9th Jun 20222:09 pmRNSDirector/PDMR Shareholding
12th May 20222:05 pmRNSDirector/PDMR Shareholding
12th May 20222:01 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSDividend Policy Update
28th Apr 20223:24 pmRNSAGM Statement
14th Apr 202211:20 amRNSDirector/PDMR Shareholding
28th Mar 20224:19 pmRNSAnnual Financial Report
18th Mar 202212:54 pmRNSDirector/PDMR Shareholding
18th Mar 202212:52 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSAnnual Financial Report
9th Mar 20225:42 pmRNSDirector/PDMR Shareholding
8th Mar 20227:00 amRNSAcquisition
17th Feb 20227:00 amRNSAcquisition
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
10th Feb 20222:55 pmRNSHolding(s) in Company
9th Feb 20223:50 pmRNSDirector/PDMR Shareholding
9th Feb 202211:50 amRNSDirector/PDMR Shareholding
3rd Feb 202210:10 amRNSNotice of Results
26th Jan 202211:51 amRNSDirector/PDMR Shareholding
10th Jan 202211:43 amRNSDirector/PDMR Shareholding
29th Dec 20211:07 pmRNSConversion of UK operations to a REIT
21st Dec 20216:25 pmRNSPDMR Notification
16th Dec 20217:00 amRNSCLS secures five new leases in Germany
9th Dec 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20219:52 amRNSDirector Declaration
11th Nov 202111:40 amRNSDirector/PDMR Shareholding
9th Nov 20219:24 amRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSTrading Update
13th Oct 20217:00 amRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSCLS secures two new leases in Germany
20th Sep 20215:43 pmRNSDirector/PDMR Shareholding
10th Sep 20215:26 pmRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNSChange of Auditor
11th Aug 20217:00 amRNSSustainability strategy launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.